A unified genetic, computational and experimental framework identifies functionally relevant residues of the homing endonuclease I-BmoI by Kleinstiver, Benjamin P. et al.
A unified genetic, computational and experimental
framework identifies functionally relevant residues
of the homing endonuclease I-BmoI
Benjamin P. Kleinstiver
1, Andrew D. Fernandes
1,2, Gregory B. Gloor
1 and
David R. Edgell
1,*
1Department of Biochemistry, Schulich School of Medicine & Dentistry and
2Department of Applied Mathematics, The University of Western Ontario, London, ON N6A 5C1, Canada
Received November 11, 2009; Revised December 18, 2009; Accepted December 20, 2009
ABSTRACT
Insight into protein structure and function is best
obtained through a synthesis of experimental, struc-
tural and bioinformatic data. Here, we outline a
framework that we call MUSE (mutual information,
unigenic evolution and structure-guided
elucidation), which facilitated the identification of
previously unknown residues that are relevant for
function of the GIY-YIG homing endonuclease
I-BmoI. Our approach synthesizes three types
of data: mutual information analyses that identify
co-evolving residues within the GIY-YIG catalytic
domain; a unigenic evolution strategy that identifies
hyper- and hypo-mutable residues of I-BmoI; and
interpretation of the unigenic and co-evolution
data using a homology model. In particular, we
identify novel positions within the GIY-YIG domain
as functionally important. Proof-of-principle experi-
ments implicate the non-conserved I71 as function-
ally relevant, with an I71N mutant accumulating a
nicked cleavage intermediate. Moreover, many
additional positions within the catalytic, linker and
C-terminal domains of I-BmoI were implicated
as important for function. Our results represent
a platform on which to pursue future studies of
I-BmoI and other GIY-YIG-containing proteins, and
demonstrate that MUSE can successfully identify
novel functionally critical residues that would be
ignored in a traditional structure-function analysis
within an extensively studied small domain of  90
amino acids.
INTRODUCTION
The explosion of sequence and structural data has rapidly
accelerated the pace of protein structure and function
studies. Bioinformatic approaches that predict function
based on amino-acid conservation (1,2), homology mod-
elling studies (3) and identiﬁcation of co-evolving residues
(4,5) are among methods commonly used to address struc-
ture and function questions. There are, however, many
protein families for which mechanistic insight is lacking.
The GIY-YIG homing endonuclease family is one such
example. Homing endonucleases are site-speciﬁc yet
sequence-tolerant DNA endonucleases that are distin-
guishable from other DNA endonucleases in their ability
to bind long target sequences and tolerate multiple substi-
tutions within their binding site (6). They function primar-
ily as mobile genetic elements, initiating the movement of
their coding sequence and surrounding DNA by binding
and cleaving a target site (the homing site) in genomes that
lack the endonuclease (7). Homing endonucleases are
phylogenetically widespread, and have traditionally been
categorized into one of four large families based on
conserved amino-acid motifs, the LAGLIDADG, HNH,
His-Cys box and GIY-YIG families (6). The PE-(D/E)-
XK and Vsr-like enzymes are only recently described
and have fewer family members (8,9). Much eﬀort has
been devoted towards re-engineering LAGLIDADG
endonucleases to cleave novel target sequences with
clinical relevance in the human genome (10–13). Similar
studies could in principle be performed on any
endonuclease family, necessitating a detailed understand-
ing of mechanism.
Within the four largest endonuclease families, the
GIY-YIG endonucleases are the least understood
in terms of mechanism. The prototypical GIY-YIG
family endonuclease is I-TevI, encoded with the genome
of Escherichia coli phage T4 (14). Studies on I-TevI
revealed that the enzyme has a two-domain structure,
composed of a N-terminal catalytic domain containing
the class-deﬁning GIY-YIG motif that is connected to a
C-terminal DNA-binding domain by a ﬂexible linker (15).
Substantial experimental evidence suggests that the
DNA-binding domain tethers the catalytic domain on its
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generate a staggered 2-nt 30 overhang (16). The catalytic
domain has no measurable DNA-binding activity when
expressed independently, and a critical function of the
linker region in I-TevI, and its isoschizomer I-BmoI, is
to correctly position the domain on substrate (17–19).
Early bioinformatic studies revealed that the GIY-YIG
domain is not exclusive to homing endonucleases (20),
illustrated by the presence of the domain in the UvrC
nucleotide excision repair protein (21), restriction
enzymes (22,23), and retrotransposable elements (24).
Structural, biochemical and bioinformatic studies have
shown that the GIY-YIG domain is  90 amino acids
with an a/b-fold composed of a central three-stranded
antiparallel b-sheet ﬂanked by three helices (21,25)
(Figure 1). Four highly conserved residues in the
GIY-YIG domain, Y17, R27, E74 and N87 (numbered
according to the I-BmoI sequence, Figure 1B) comprise
a putative active site cleft (Figure 1C), with a single
divalent metal ion coordinated by the glutamic-acid
residue in both the I-TevI and UvrC structures.
Mutation of any of these residues abolishes DNA
cleavage activity in a number of GIY-YIG enzymes
(20–22,26,27).
In spite of a wealth of bioinformatic, biochemical and
structural data, the mechanism by which GIY-YIG
homing endonucleases introduce a double-strand break
(DSB) in substrate is unknown (28). The mechanism
must involve repositioning of a (presumably) single
active site within the catalytic domain on substrate
to perform two sequential nicking reactions, with the
bottom (non-coding) strand nicked before the top
(coding) strand (27,29). This mechanism is likely to be
distinct from other enzymes that contain the GIY-YIG
domain, including the restriction enzyme Cfr42I that func-
tions as a tetramer (30), Eco29kI that functions as a dimer
(31), or the UvrC proteins that nick only a single-strand
adjacent to a damaged base (21). In an eﬀort to gain
insight into the mechanism by which GIY-YIG homing
endonucleases introduce a DSB, we have been studying
I-BmoI (Figure 1), (32). Like I-TevI, I-BmoI is a
two-domain endonuclease with an extended recognition
sequence. Both enzymes cleave at the same positions
within their respective intronless substrates, but I-BmoI
requires only a critical G-C base pair at position  2o f
intronless substrate for cleavage (33). As a model
GIY-YIG homing endonuclease, I-BmoI has a number
of advantages over I-TevI, including the fact that the
wild-type (WT) enzyme can be overexpressed and
puriﬁed in quantities that are diﬃcult to obtain with
I-TevI. Moreover, I-BmoI is  750-fold less active than
I-TevI, suggesting that early steps in the reaction
pathway are more amenable to in vitro analysis (27,33).
Here, we present a uniﬁed experimental framework that
will provide a platform on which to base future structure
and function studies of GIY-YIG homing endonucleases,
and other GIY-YIG-containing enzymes. Our framework,
which we term MUSE, synthesizes data from three distinct
experimental approaches; mutual information analyses
that identify co-evolving residues in the GIY-YIG
domain, a unigenic evolution strategy that uses a
functional genetic selection to identify hypo- and hyper-
mutable residues, and interpretation of the data using
paralog-speciﬁc sequence alignments and structural
models of the GIY-YIG domain. While none of the
approaches used in our study are individually novel,
the synthesis of data from all three methods facilitated
the identiﬁcation of residues that are unlikely to have
been identiﬁed as important for function using any one
of the approaches in isolation. Mutational analyses of the
positions revealed phenotypic diﬀerences relative to WT
I-BmoI in functional assays, validating that MUSE can
successfully identify previously unrecognized residues
with the GIY-YIG domain as relevant for function.
Figure 1. I-BmoI is a modular GIY-YIG homing endonuclease.
(A) Schematic representation of I-BmoI interactions with intronless
thyA substrate based on biochemical data (27,32). Top- and
bottom-strand nicking sites are shown as open and ﬁlled triangles,
respectively, and the critical  2 GC base pair is shown in enlarged,
bold-type font. The intron insertion site is indicated by a vertical line,
with exon 1 sequence upstream ( ) and exon 2 sequence downstream
(+). (B) Homology model of the I-BmoI catalytic domain (residues
1–88). Highlighted are four highly conserved residues in GIY-YIG
alignments that are critical for function, and secondary structure
elements of the domain. Subsequent illustrations of the catalytic
domain will be shown from this view (front) or a 180-degree rotation
(back). (C) Surface representation of a front view of the I-BmoI
homology model highlighting the putative catalytic cleft. The side
chains of Y17, R27, E74 and N87 are surface exposed, lie along the
base of the cleft, and are situated in close proximity to one another.
Patches of charge are shown in colour, blue being positive, red being
negative and green being hydrophobic.
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Strain and plasmid construction
Strains and plasmids used in this study are listed
in Supplementary Table S1, and oligonucleotides are
listed in Supplementary Table S2. To construct
strain BW25141( DE3) for use in unigenic evolution
experiments, E. coli BW25141 was lysogenized using
the  DE3 lysogenization kit (Novagen). The toxic
plasmid backbone, p11-lacY-wtx1 (34), was used to con-
struct pToxBmoHS and pToxBmoIn
+ by inserting the
corresponding intronless homing site (HS) and
intron-containing target site (In
+), respectively. To con-
struct pToxBmoHS, oligonucleotides DE-395 and DE-396
were annealed and ligated into the XbaI and SphI sites of
p11-lacY-wtx1. The 51-bp intronless homing site corre-
sponds to positions  10 to +41 of the exon1–exon2
junction relative to the intron insertion site (32). To con-
struct pToxBmoIn
+, oligonucleotides DE-429 and
DE-430 were annealed and ligated into the XbaI and
SphI sites of p11-lacY-wtx1. The 51-bp intron-containing
site corresponds to the ﬁnal 10bp of the 30-end of the
intron plus the ﬁrst 41bp of the 50-end of exon 2 (32).
pIBmoI
E, which is a pUC57 derivative containing a
codon optimized I-BmoI gene (IDT DNA), was used as
a template for cloning the I-BmoI gene (optimized I-BmoI
sequence is presented in Supplementary Figure S1).
Primers DE-331 and DE-384 were used to amplify and
clone the codon optimized I-BmoI into the NdeI and
XhoI sites of pACYCDuet-1 to generate pACYCIBmoI.
This plasmid was subsequently used as a template to gener-
ate pACYCR27A using the Quikchange XL site-directed
mutagenesis kit (Stratagene) with primers DE-419 and its
reverse complement, DE-420. All plasmid constructs were
veriﬁed by sequencing.
Genetic selection
To generate strains harbouring the toxic plasmid for
unigenic evolution, BW25141( DE3) was transformed
with one of the three toxic (reporter) plasmids
(p11-lacY-wtx1, pToxBmoHS, or pToxBmoIn+) and
plated on LB plates containing 100mg/ml ampicilin and
0.2% glucose. For each strain, a single colony was picked
to inoculate 500ml LB plus 100mg/ml ampicilin and 0.2%
glucose to generate electrocompetent cells. Typically, 50ml
of electrocompetent cells were transformed with 100ng of
the expression plasmid (pACYCIBmoI or pACYCR27A).
The transformations were allowed to recover in 500mlo f
SOC media at 37 C for 5min, then diluted into 2ml 37 C
SOC and shaken at 37 C for 75min. We found that
addition of IPTG was not necessary to induce I-BmoI
expression, as an IPTG concentration of 0.1mM led
to toxic eﬀects. After incubation, transformations were
diluted 1000-fold in SOC, and 100-ml aliquots were
spread on plates containing LB plus 25mg/ml
chloramphenicol to estimate number of transformants,
or plates containing LB plus 25mg/ml chloramphenicol
and 10mM arabinose to observe the number of colonies
surviving the selection. Survival rate was calculated
by dividing the number of colonies observed on
chloramphenicol plus arabinose plates by colonies
observed on chloramphenicol only plates.
Construction of mutagenized I-BmoI libraries
I-BmoI mutant libraries were generated by error-prone
PCR from pACYCIBmoI using primers DE-490 and
DE-491. The forward primer (DE-490) was designed
such that only the ATG start codon was included in the
primer, and the reverse primer (DE-491) was designed
such that no part of the I-BmoI gene was present in the
primer. Three mutagenic libraries were generated using
identical PCR conditions in parallel 50-ml reactions con-
taining 80ng of pACYCIBmoI as template, 20pmol of
each primer (DE-490, DE-491), 0.2mM dATP, 0.2mM
dGTP, 1mM dCTP, 1mM dTTP, 0.5mM MgCl2,
0.5mM MnCl2 and 2.5U of Taq polymerase (NEB) in
the presence of 1 PCR buﬀer (10mM KCl, 10mM
(NH4)2SO4, 20mM Tris–HCl pH 8.8, 2mM MgSO4,
0.1% Triton X-100). A total of 30 PCR cycles were run
as follows: 94 C for 60s, 46.5 C for 60s and 72 C for 60s.
Mutagenic PCR products were digested with NdeI and
XhoI and ligated into pACYCR27A (used as a ligation
target due to the fact that re-ligated singly cut R27A
I-BmoI would be non-functional in the selection). The
ligated pools were independently transformed into
DH5a, grown in 3ml LB plus 25mg/ml chloramphenicol
for 16h at 37 C, and miniprepped (QIAGEN) to generate
the mutant I-BmoI libraries.
I-BmoI unigenic evolution and selection of variants
The three mutagenic libraries were subjected to unigenic
evolution to determine survival percentage and to obtain
clones required for sequence analysis. We sequenced a
total of 167 selected clones picked from LB plus
chloramphenicol and arabinose plates, of which 87 inde-
pendent clones (36, 34 and 17 clones from pools 1,
2 and 3, respectively) were identiﬁed (the rest discarded
due to redundancy of DNA or amino-acid sequence).
These clones contained a total of 460-nt substitutions
corresponding to 271 amino-acid substitutions. We also
sequenced 62 unselected clones from LB plus
chloramphenicol only plates. The unselected clones
harboured a total of 760-nt substitutions, 577
amino-acid substitutions and were used to establish
baseline mutation frequencies. The EoS value was
calculated as described (A. Fernandes et al., submitted
for publication).
Construction and puriﬁcation of site-directed mutants
We created a library of site-directed mutants using
the Quikchange XL Site-Directed Mutagenesis Kit
(Stratagene) to generate point mutants in the
pACYCIBmoI backbone. For puriﬁcation purposes, a
subset of these mutants were sub-cloned into the pTYB1
vector and were expressed and puriﬁed as previously
described with one change to the protocol (27). Once the
clariﬁed lysate has been loaded, the ﬁve column volume
wash with Buﬀer A contained a ﬁnal concentration of
1mM ATP (Bioshop Canada Inc.) to help remove
bound chaperones. The concentrations of puriﬁed WT
Nucleic Acids Research,2010, Vol.38, No. 7 2413I-BmoI and I-BmoI mutants were determined by a
standard Bradford assay in duplicate using an Ultrospec
2100 pro (Biochrom Ltd).
Characterization of I-BmoI variants
A set of I-BmoI variants identiﬁed from the unigenic evo-
lution study and the library of site-directed mutants were
run through the genetic selection (as described above) to
determine their survival versus WT. Cleavage assays were
subsequently performed with I-BmoI mutants that were
amenable to puriﬁcation. The cleavage activities of WT
and I-BmoI mutants were determined using titrations
with 10nM pBmoHS and 2-fold serial dilutions of
I-BmoI from 700nM to 1.37nM in 10-ml volumes for
5min at 37 C in 50mM Tris pH 7.9, 50mM NaCl,
2mM MgCl2 and 1mM DTT. Reactions were stopped
by addition of 4ml stop dye (100mM EDTA pH 8.0,
25% glycerol and 0.2% bromophenol blue) and heated
at 90 C for 5min. Stopped reaction were run on 1%
agarose gels, stained with ethidium bromide (OmniPur)
and analysed on an AlphaImager
TM3400 (Alpha
Innotech). Percent linear DNA is deﬁned as the percent-
age of total DNA (circular, nicked and linear) converted
to linear product. Nicking assays were conducted as
above, with a standard protein concentration of 175nM
and 10-ml aliquots of a reaction pool were stopped at 15s,
30s, 45s, 1min, 1min 30s, 2min, 3min and 5min. The
rate constants for the ﬁrst strand (circular to nicked) and
second strand (nicked to linear) steps were calculated as
described in Supplementary Figure S4.
Structure-based alignment
Sequences similar to the endonuclease domain of I-TevI
(GI: 29345254) were identiﬁed by BLAST in the
non-redundant protein database and in the metagenomic
protein database at NCBI. All proteins with an E-value
less than 0.1 were aligned to the I-TevI catalytic domain
structure (PDB ID: 1LN0) using the block align feature of
Cn3D (http://www.ncbi.nlm.nih.gov/Structure/CN3D/
cn3d.shtml). The defaults of this feature were changed to
not perform global alignments and to allow changes to the
block structure of existing alignments. Long gaps were not
allowed. Totally 174 full-length sequences were identiﬁed.
Partial sequences, sequences that required large gaps or
that were missing the presumed catalytic residues (R27,
E75 and N90, I-TevI numbering) were excluded from
the alignment. The alignment included the I-BmoI
sequence (GI: 12958590). The alignment contained four
bacteriophage sequences, 97 sequences from the marine
metagenome, 23 bacterial sequences and 50 eukaryotic
sequences (Supplementary Figure S2). The sequences
were culled to remove the shorter member of a redundant
pair with a threshold of 90% using JalView (35), leaving
146 sequences. To test the quality of the alignment and
for contamination by paralogous GIY-YIG sequences, the
UvrC sequence from Thermotoga maritima (GI: 8134799)
was included in the initial alignment. Using the Cn3D
block align method, the sequences were sorted by
matches to the position sensitive scoring matrix. The
T. maritima UvrC sequence was the third worst scoring
protein by this measure, suggesting that UvrC proteins
were eﬀectively excluded from the alignment. Second, we
examined the alignment for an excess of local covariation
that can detect as little as 10% contamination of the align-
ment (R.J. Dickson et al., submitted). This often results
when paralogous gene families are incorporated into one
alignment. No excess local covariation was identiﬁed, sug-
gesting that contamination by UvrC or other parologous
GIY-YIG type endonuclease domains was rare. Based on
the alignment, we built a homology model of the I-BmoI
GIY-YIG domain (residues 1–88) using MODELLER
(36) and SWISS-MODEL (37) with the I-TevI structures
(1KM0 and 1LN0) as templates. There was no signiﬁcant
diﬀerence between the two structural models.
Co-variation analyses
Three semi-independent methods, MIp (38), DZp and
DZpx (R.J. Dickson et al., submitted), were applied to
the multiple sequence alignment to identify pairs or
small groups of positions that showed non-independent
evolution in the GIY-YIG domain, using scoring cutoﬀs
of 4.5 (MIp), 3.5 (DZpx) and 1.5 (DZp), respectively.
Mutual information values were assigned to residues
using the I-BmoI reference sequence. Distances were
calculated using the closest non-hydrogen atom of
co-evolving residues in the I-BmoI homology model.
RESULTS
Improved alignment of the GIY-YIG domain
Previous multiple sequence alignments of the GIY-YIG
domain have included sequences of proteins with diverse
functions, diluting the phylogenetic signal from GIY-YIG
domains speciﬁc to homing endonucleases (20,23). To gain
better insight into residues that are conserved amongst
potential GIY-YIG homing endonucleases, we collected
sequences by BLAST and aligned them to the I-TevI
catalytic domain structure with Cn3D. BLAST searches
were dominated by matches to the nucleotide excision
repair protein UvrC, all of which were subsequently
discarded. In addition, sequences that contained obvious
insertions and deletions, or sequences that lacked residues
equivalent to the functionally critical R27, E74 and N87
(I-BmoI numbering), were removed resulting in a ﬁnal
alignment of 146 sequences.
The GIY-YIG domain has previously been separated
into ﬁve conserved regions that are characterized by
highly conserved residues, termed motifs A through E
(20). In our new alignment (Figure 2A), the information
content associated with the highly conserved residues has
not changed signiﬁcantly, with the exceptions of increases
associated with the tyrosine residues of motif A (Y6 and
Y17) and the phenylalanine residue of motif C (F57).
There are, however, diﬀerences outside of the highly
conserved residues that are apparent in our alignment.
In particular, there are obvious increases in the informa-
tion content of positions that intervene the GIY and
YIG elements of motif A (I8, N10 and K15), and the
stretch of residues (S48, K51, H52, G53) that precede
the phenylalanine (F57) of motif C. In contrast, there is
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residue (position 84) that precedes the conserved
tyrosine (Y86) and asparagine (N87) residues of motif E
(Figure 2A), attributable to the removal of UvrC
sequences from the alignment that predominantly
possess a proline at this position.
To display sequence conservation within the GIY-YIG
domain, the entropy for each position in the alignment
was calculated and subsequently displayed on the
I-BmoI homology model, with conserved positions (low
entropy, high information content) coloured green and
non-conserved positions (high entropy, little information
content) coloured white (Figure 2B). As expected, the
highly conserved residues that characterize the GIY-YIG
domain (Y6, Y17, R27, E74 and N87) all surround the
proposed catalytic surface. Of particular interest is H31
that displays high information content, and lies in close
proximity to the essential R27 in a-helix1, with both
residues stacked against each other and orientated
towards the presumed catalytic surface (Figure 2B). In
general, the majority of conserved residues are similarly
positioned, with the exception of a block of moderately
conserved residues spanning positions 47–53 (located in
a-helix 2, orientated away from the catalytic surface).
Strikingly, many of the non-conserved residues occupy
positions distinct from the proposed catalytic surface,
including residues in a-helix 1 and the loop connecting
a-helix 1 and a-helix 2. Collectively, these data highlight
the conservation of residues that surround the proposed
catalytic surface of the GIY-YIG domain, whereas
non-conserved residues tend to be on the periphery of
the domain.
Identiﬁcation of co-evolving positions in the I-BmoI
catalytic domain
Additional insight into functionally important residues of
the I-BmoI catalytic domain was obtained by applying
mutual information analyses to detect amino-acid posi-
tions that co-evolve, or co-vary, with each other. Such
analyses can detect non-independent evolution of
residues that co-vary with other residues because of func-
tional constraints. Indeed, most residues that co-vary tend
to be within contact distance of each other (4,38). We
applied three diﬀerent methods to analyse co-variation
in the GIY-YIG domain alignment, MIp, Zpx and
Zp (R.J. Dickson et al., submitted), and found that the
highest scoring amino-acid pair by all methods was
S20-I71 (Table 1). While S20 and I71 are not within pre-
dicted contact distance (6.3A ˚ ) in the homology model of
the I-BmoI GIY-YIG domain, they occupy a surface of
the domain that can be envisioned as a gateway to the
catalytic cleft formed by the C-terminal end of b-sheet 2
and the N-terminal end of a-helix 3 (Figure 3). In
addition, we identiﬁed a set of four residues,
Figure 2. Alignment of the GIY-YIG domain. (A) Multiple sequence alignment of 146 sequences represented as a sequence logo (50). Positions are
numbered according to the I-BmoI sequence that is shown below the alignment (conserved functionally critical residues are shown in green).
Predicted secondary structure elements of the I-BmoI GIY-YIG domain are indicated on the sequence by shading, and motif assignments are
identiﬁed on the alignment with shaded boxes. (B) Front (left) and rear (right) views of the homology model with the degree of conservation mapped
onto the structure. Conserved positions are shown in dark green, with the side chains of highly conserved residues indicated. Variable positions are
shown in white.
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1). This set of residues was of interest because the H40Y
mutation in I-TevI reduces catalytic activity relative to the
WT protein (39), and the interaction between these
residues may be required to position the H40 residue
appropriately within the active site (Figure 3). Another
intriguing residue identiﬁed by mutual information
analyses was K7 that coevolves with three other
residues, T9, F16 and E60 (Table 1). All four residues lie
in adjacently positioned b-sheets (Figure 3), suggesting
that interaction between these residues is critical for
folding of the GIY-YIG domain. Similarly, other sets of
coevolving residues such as K51-H52 and H63-K73-W76
(Table 1), are all within contact distance of each other and
likely have roles in folding or stability of the domain.
Unigenic evolution identiﬁes mutable positions in I-BmoI
The above results provided a phylogenetic and structural
framework for the identiﬁcation and analysis of potential
functionally critical residues in the catalytic domain of
I-BmoI. To gain experimental insight into residues that
are functionally relevant across the full length of
I-BmoI, we adapted the unigenic evolution method (40).
In this method, a genetic selection is used to isolate func-
tional variants of I-BmoI after random mutagenesis,
facilitating identiﬁcation of amino-acid positions that
were either tolerant (hypermutable) or intolerant
(hypomutable) of substitutions. The selection utilizes a
two-plasmid system that relies on I-BmoI expression
from one plasmid (pExp) to cleave a second, toxic
plasmid (pTox) that contains the cognate I-BmoI
homing site (34) (Figure 4). Cells survive plating on selec-
tive media only if the toxic plasmid has been cleaved by a
functional I-BmoI. As shown in Figure 4, we observed a
survival ratio of 0.95 when WT I-BmoI was expressed
from pExp, and pTox contained the I-BmoI homing site
(pToxBmoHS). In contrast, survival ratios of 0 were
observed when WT I-BmoI was used with the pTox
backbone (p11-lacY-wtx1) containing no homing site,
and when a catalytically inactive I-BmoI variant, R27A,
was used in combination with pToxBmoHS. Furthermore,
the survival ratio was <0.0001 when pTox contained the
Figure 3. Co-evolving residues of the I-BmoI catalytic domain. Position of four sets of co-evolving residues mapped onto the I-BmoI homology
model, colour-coded by co-evolving residues (yellow, L35, H40, N46, F49; red S20, I71; blue K7, T9, F16, E60; orange K51, H52). Front (left) and
rear (right) views are shown, with functionally critical residues highlighted in light green.
Figure 4. The two-plasmid genetic selection. (A) Schematic of the
expression plasmid (pExp) and toxic (reporter) plasmid (pTox).
(B) Veriﬁcation of the genetic selection using variants of pExp and
pTox. Survival rates are expressed as the ratio of colonies on chlo-
ramphenicol + arabinose plates to colonies on chloramphenicol only
plates. WT I-BmoI, pExp expressing WT I-BmoI; R27A I-BmoI, pExp
expressing an inactive R27A I-BmoI; randomized I-BmoI, library of
I-BmoI variants; p11-lacY-wtx1, parental pTox without I-BmoI target
site; ND, not determined.
Table 1. Co-evolving residues in the I-BmoI GIY-YIG domain
Pair MIp DZpx DZp Distance (A ˚ )
S20-I71 8 5.7 5.5 6.3
H63-K73 4.8 3.8 3.5 3.1
K51-H52 4.7 4.3 2 1.3
K7-E60 4.1 3.6 2 3
L35-N46 5.2 3.4 1.8 3.7
K7-F16 3.9 3.7 1.8 4.2
K73-W76 6 4.6 1.8 3.3
K7-T9 3.2 3 1.8 3.8
Q75-D79 3.8 4.1 1.8 3.1
L35-F49 3.5 3.2 1.7 3.6
N10-S48 4.6 3.9 1.6 3
L35-H40 4.7 3.4 1.5 3.5
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+),
which I-BmoI cleaves poorly (33). These results validate
the genetic selection system, showing that cells survive
only when I-BmoI can cleave the toxic plasmid that
contains the I-BmoI homing site.
We used error-prone PCR to generate three indepen-
dent libraries of I-BmoI variants in pExp, mutagenzied
over the entire I-BmoI coding region. The libraries were
transformed into the selection strain carrying
pToxBmoHS, and survivors identiﬁed by plating on selec-
tive media with an average survival ratio of  0.01 for the
three pools. We identiﬁed and sequenced 87 independent
I-BmoI variants that survived the selection, containing an
average of 5.28-nt substitutions (or 3.11 amino-acid sub-
stitutions) per clone (Supplementary Figure S3). To
determine the baseline mutation frequencies inherent to
the error-prone PCR method, we sequenced 62 indepen-
dent clones plated on non-selective media, which con-
tained an average of 12.26-nt substitutions per clone
(Supplementary Figure S3). As expected, the average
number of substitutions in the pool of unselected clones
was much greater than the number in the selected pool,
and the distribution of the number of changes between the
selected and unselected clones diﬀered.
By mapping the mutable positions from the selected
clones onto the I-BmoI sequence, we found that
amino-acid positions tolerant to substitutions were
distributed throughout the length of the coding region
(Figure 5). To gain further insight into tolerated muta-
tions within the GIY-YIG catalytic domain, the mutable
Figure 5. Unigenic evolution analysis of I-BmoI. Shown is a summary of the mutations found in the 87 selected clones and the EoS value for each
position. Non-synonymous substitutions found at each position are indicated beneath the corresponding I-BmoI sequence over the entire length of
the protein (multiple independent occurrences of the same mutation are shown in subscript). Shown above each line of sequence is a graph of the
evidence of selection (EoS) at each amino-acid position of I-BmoI. Regions of modelled or predicted secondary structure are indicated by grey
rectangles, and bold residues indicate the GIY and YIG motifs, functionally critical residues, or residues that are identical between I-BmoI and
I-TevI in the linker domain.
Nucleic Acids Research,2010, Vol.38, No. 7 2417residues from positions 1–88 were mapped onto a
homology-based 3D model of the I-BmoI catalytic
domain (Figure 6). Interestingly, the majority of the muta-
tions mapped to the periphery or the backside of the
catalytic domain (opposite the proposed catalytic
surface). Also, few mutations were observed near the
proposed catalytic surface and no substitutions were
observed in the four functionally critical residues (Y17,
R27, E74 and N87). Some positions tolerated the same
substitution more than once, as evidenced by the appear-
ance of the same mutation in independent clones that con-
tained an alternate set of accompanying mutations
(Supplementary Table S3). For example, residue N12
tolerated 10 amino-acid substitutions (ﬁve to aspartate,
four to threonine and one to tyrosine) in diﬀerent
clones, indicating that the position is highly mutable.
The signiﬁcance of mutations in positions outside of the
I-BmoI catalytic domain were diﬃcult to interpret due to
the absence of similarity between the DNA-binding
domain of I-BmoI and that of I-TevI, for which there is
an available structure. However, the I-BmoI and I-TevI
linker regions, encompassing residues 95–112 of I-BmoI,
show some degree of similarity (18). In particular,
alanine-scanning mutants in this region of I-TevI func-
tionally divided the linker into deletion intolerant and
deletion tolerant regions (17,20). The equivalent deletion
intolerant region of the I-BmoI linker appeared to contain
few mutations among the selected clones (Figure 5), with
Figure 6. Mapping positions that tolerate non-synonymous substitutions and EoS data onto the I-BmoI homology model. For the left of each panel,
amino-acid positions that tolerate non-synonymous substitutions are shown in red and positions where no change was found are in white. On the
right of each panel, the EoS score is shown as gradient. Positions with high EoS values are blue, and low EoS values are white. (A) Ribbon
representations of a front view of the catalytic domain, with functionally critical residues identiﬁed by the present and previous studies indicated.
(B) Surface representation of a front view of the I-BmoI catalytic domain, with the putative catalytic cleft bounded by white dashed lines. (C) Surface
representation of a rear view of the catalytic domain.
2418 Nucleic Acids Research, 2010,Vol.38, No. 7some amino-acid positions exhibiting high statistical
conﬁdence that the lack of mutation was not due to
random chance (see below).
Statistical analysis of unigenic evolution data reveals
residues of potential functional importance
More rigorous interpretation of the unigenic evolution
data to identify hypo- and hyper-mutable residues
requires statistical analyses to determine the probability
that any codon will undergo a synonymous or non-
synonymous change, taking into account the expected
substitution frequencies based on the bias of the
mutagenic PCR and the base composition of individual
codons. Previous methods utilized a statistic, H, varying
between  1 and 1, to determine the mutability of an indi-
vidual amino-acid position (40,41). We found that H both
over- and under-estimates the mutability of positions
because it lacks the power to determine if a signiﬁcant
diﬀerence exists between the selected and unselected
clones at each position (A. Fernandes et al., submitted
for publication). For instance, the number of
hypomutable residues in a given protein was vastly
overestimated by assigning a value of  1 for any residue
that had no non-synonymous changes, whereas there
will be many positions that do not contain sequence
changes simply because the mutagenic method is not
saturating.
To take this, and other issues into consideration, we
developed a new method for analysing unigenic evolution
data called EoS (Evidence of Selection) (A. Fernandes
et al., submitted for publication). The EoS value assesses
whether the observed frequency of substitutions for any
given codon in the selected clones is statistically diﬀerent
from the expected frequency of mutations based on data
for the same codon from the unselected pool of clones.
Importantly, the EoS value explicitly represents both
selection and the power to detect selection for each
residue, and is plotted as the log2 ratio of the probability
of non-random changes per codon versus the probability
of random changes per codon. Thus, an EoS value of 8
represents a 1 in 256 probability that the observed
spectrum of mutations occurred at random. Moreover,
the fact that some residues possess low EoS scores does
not necessarily indicate that these residues are not of
potential functional signiﬁcance, only that the sample
size is insuﬃcient to determine their signiﬁcance.
For example, A/T rich codons are more likely to be
mutated due to the bias of Taq polymerase, whereas
G/C rich codons are less likely to be mutated. Under the
EoS method, a lysine codon (AAA) for which there were
no non-synonymous changes in the selected clones would
be ﬂagged as signiﬁcant only if substitutions were
observed at the same codon in the unselected clones. As
an example, consider position K130. Six non-synonymous
substitutions were present in the unselected clones at this
position, whereas no substitutions were observed in the
selected clones at this position (Supplementary Table
S3). Because the spectrum of observed substitutions in
the selected clones was signiﬁcantly diﬀerent from the
observed and expected spectrum of mutations in the
unselected clones, K130 is assigned a high EoS value of
8.03, thus providing strong evidence that the position is
intolerant to substitution. In contrast, K171 has a low EoS
value of  0.65 because a similar spectrum of mutations
was observed in the both the selected and unselected
clones at this position (Supplementary Table S3).
Using the EoS value as a guide, many positions
throughout the length of I-BmoI appear to have potential
functional importance (Figure 5). Of particular interest
were residues in the catalytic domain that have a high
EoS value. For example, K29, N42, N50, K51, F57, I67,
I71, N80 and Y82 all have EoS values greater than 6.
Apart from F57, none of these positions have been
implicated by previous studies to be of potential func-
tional importance. We mapped the EoS values of
residues onto the I-BmoI homology model, and
compared this representation to that of the mutable
amino-acid residues mapped onto the model (Figure 6).
Residues that line the catalytic surface were refractory to
mutation in the selected clones (Figure 6A and B, and
coloured white), whereas the EoS values indicate that
the majority of these residues are predicted to be function-
ally critical (Figure 6A and B, and coloured blue). Many
residues with high EoS scores were located away from the
active site surface (Figure 6B and C), consistent with
structural roles (for instance, K51, which strongly
co-evolves H52; Table 1). Again, it is important to note
that residues with a low EoS value (coloured white in
Figure 6) do not imply that this position is not of potential
signiﬁcance, only that we lack the statistical power to
draw such a conclusion given the observed spectrum of
mutations (for example, R27).
Inspection of EoS values for the remainder of the
I-BmoI sequence revealed that many residues in the
linker and C-terminal region appear to be of potential
functional signiﬁcance (Figure 5). For instance, two
residues in the linker region that are identical between
I-TevI and I-BmoI, K105 and K111, possesses EoS
values >8. These residues in I-BmoI are excellent candi-
dates for future mutagenic studies because they corre-
spond to the deletion intolerant region of the I-TevI
linker, where mutations drastically reduced or abolished
cleavage activity (17,20).
Genetic analysis of site-directed mutants
The data generated by mutual information and unigenic
evolution facilitated the identiﬁcation of amino acids of
potential functional importance that could be tested
through mutational analyses. We focussed on amino-acid
positions within the N-terminal catalytic domain, because
these positions could be interpreted within the context of
known and modelled GIY-YIG domain structures and
previous mutagenic studies, and because mutations in
the catalytic domain would not aﬀect the DNA-binding
activity of I-BmoI (15,32). Thus, we could be conﬁdent
that any phenotype we observed for site-directed
mutants was due to a defect related to the function of
the catalytic domain. We selected amino-acid positions
for mutagenesis based on one of the following criteria:
(i) the position had a high EoS value, (ii) the residue(s)
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(iii) the residue possessed high information content in
the alignment and had not been previously analysed by
mutational studies. For instance, H31 was chosen for
mutagenesis because it possessed high information
content, had a moderate EoS value of 3.52, and has not
previously been targeted by mutagenesis studies of
GIY-YIG homing endonucleases. In contrast, position
71, an isoleucine in I-BmoI, displayed very low informa-
tion content, yet had a high EoS value of 6.37.
Furthermore, I71 co-evolves with S20, thus both
residues were chosen for further analyses. The rationale
for choosing other amino-acid positions for mutagenesis is
provided in Supplementary Table S4. In addition to
generating site-speciﬁc mutants, we chose two clones
identiﬁed in the unigenic evolution study that contained
single mutations within the catalytic domain (N12D and
H52R) for further analyses. These clones are representa-
tive of amino-acid positions within the catalytic domain
that are tolerant to change.
To determine if the identiﬁed residues were indeed
critical for I-BmoI function, we individually analysed the
mutants using the genetic selection, allowing us to calcu-
late a survival ratio that could be directly compared to
that for WT I-BmoI. As shown in Table 2, the mutants
could be divided into four classes. Class I mutants, Y17F,
Y17H, S20A, H31F, H31Y, N42D and N42A, showed the
most dramatic eﬀect as none survived the selection. Class
II mutants were severely compromised in their survival,
with ratios <0.07, and included H31A and I67N. Class III
mutants, S20Q, H52R, I71N and I71A, exhibited
moderate survival ratios of between 0.14 and 0.43. The
class IV mutants, N12D, S48A, K51L, H52Y and Y86F
all showed survival ratios essentially equivalent to WT
I-BmoI, and thus were considered to have little eﬀect on
I-BmoI activity. We considered the possibility that a lack
of survival in the selection could be due to the generation
of a hyperactive mutant or an altered speciﬁcity mutant,
resulting in a toxic endonuclease that would cause
cell death. For all mutants, however, we observed no
reduction in viable cells when cultures were plated on
non-selective media during the selection protocol, suggest-
ing that none of the mutants were toxic. Furthermore, we
puriﬁed the H31A and N42D mutants and found by
in vitro cleavage assays that both mutants were severely
compromised for cleavage activity (see below and
Figure 7), suggesting that the lack of survival in the
genetic selection was due to loss of endonuclease activity.
Cleavage assays with key site-directed mutants
To better understand the eﬀect of individual mutations on
endonuclease activity, we next puriﬁed key site-directed
mutants (N12D, S20Q, H31A, N42D, I67N and I71N)
for use in in vitro cleavage assays (Figures 7 and 8). The
H31Y and I71A mutants were insoluble and not studied
further, and apart from the N12D mutant, mutants with
similar survival ratios to WT I-BmoI in the genetic assay
were not puriﬁed for cleavage assays (Table 2). We ﬁrst
analysed the activity of the mutant proteins relative to WT
I-BmoI over a wide range of protein concentrations in
cleavage assays using a circular plasmid substrate that
contained a single I-BmoI homing site. As shown in
Figure 7. Cleavage activity of WT I-BmoI and site-directed mutants.
(A) Shown are representative cleavage assays using 2-fold serial dilu-
tions of the WT and mutant I-BmoI proteins, from 700nM on the right
to 1nM on the left. The second lane from the left (-) of each gel image
is unreacted substrate. (B) For the R27A, H31A and N42D mutants,
only the three highest protein concentrations were tested. Substrate
linearized by EcoRI is shown in the third lane from the left. Circular
(C), linear (L) and nicked (N) plasmid forms are indicated to the right
of each gel image.
Table 2. Survival ratios of I-BmoI variants with mutations in the
catalytic domain
Mutant Survival ratio
relative to WT
a
Class I Y17F 0
Y17H 0
S20A 0
H31F 0
H31Y 0
N42A 0
N42D 0
Class II H31A 0.003±0.002
I67N 0.06±0.04
Class III S20Q 0.12±0.02
H52R
b 0.43±0.04
I71A 0.22±0.03
I71N 0.20±0.03
Class IV N12D
b 1.06±0.03
S48A 1.02±0.03
K51L 0.86±0.10
H52Y 0.96±0.05
Y86F 0.99±0.04
aValues shown represent averages and standard deviation of at least
three independent trials, normalized against the survival ratio for a WT
I-BmoI selection performed in parallel.
bThe H52R and N12D mutants were isolated from the pool of selected
clones.
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exhibited a range of activities relative to WT I-BmoI.
The N12D mutant was as active as WT I-BmoI, whereas
I61N and I71N displayed intermediate cleavage activities.
The S20Q mutant was the least active, and we estimate
that this mutant retained  30% cleavage activity of WT
I-BmoI. In contrast, the H31A and N42D mutants were
severely compromised for cleavage activity, with no linear
product visible at the highest protein concentrations tested
(Figure 7B).
To gain additional insight into the observed
phenotypes, we performed time-course cleavage assays
with WT and mutant proteins to detect the appearance
of a nicked intermediate as well as the linear product
(Figure 8). These assays were performed with limiting
metal ion, as we have previously shown that this
reaction condition can eﬀectively distinguish the two
sequential nicking reactions that generate a DSB (27).
With circular plasmid substrates used in this assay, the
ﬁrst nicking reaction generates a nicked intermediate
Figure 8. Nicking assays with WT and mutant proteins. Shown are representative agarose gels of time-course assays, with time points in seconds
indicated above the gels. The second lane of each gel from the left contains unreacted substrate ( ). Circular (C), linear (L) and nicked (N) plasmid
forms are indicated to the right of each gel. Beside each gel image is a graphical representation of the disappearance of substrate and appearance of
products formed over time. Data points from three independent experiments are plotted, with a continuous line drawn through the average.
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generates a linear product. The proﬁle of the nicking
assays suggested that the I-BmoI cleavage reaction
followed the reaction scheme shown in Equation (1):
C     !
k1 N     !
k2 L ð1Þ
where C, N and L are intact plasmid substrate, nicked
intermediate and linear product resulting from a DSB.
The rate constant for the ﬁrst nicking reaction is k1, and
k2 is the rate constant for the second nicking reaction.
As shown in Figure 8 and Table 3, the reaction proﬁles
and rate constants of the WT protein and N12D mutant
were very similar, with conversion of the nicked interme-
diate to linear product complete by  120s. The reaction
proﬁles of the S20Q and I67N mutants were very diﬀerent
from WT and N12D, with k1 constants indicative of a
slower ﬁrst nicking reaction. Under conditions used in
these assays, neither reaction was complete at the end of
the time course, making it diﬃcult to determine k2 for the
S20Q and I67N mutants using Equation (1)
(Supplementary Figure S4). In contrast, Figure 8 illus-
trates that the I71N mutant displayed a similar ﬁrst
nicking step to the WT and N12D proteins, but that the
conversion to linear product was slower as indicated by
kinetic analysis (Table 3), consistent with a nicked inter-
mediate accumulating over an extended period of time
relative to WT protein. Consequently, conversion to
linear product was delayed, but still complete by the end
of the time course. Collectively, these results clearly impli-
cate residues identiﬁed by MUSE as functionally impor-
tant, as mutation of these residues generates phenotypes
that are distinct from the WT protein.
DISCUSSION
Detailed insight into protein structure and function can be
obtained by synthesizing data from multiple experimental,
computational and structural approaches. Here, we elab-
orate an experimental framework to identify previously
unknown functionally relevant residues of the GIY-YIG
endonuclease I-BmoI that takes into account evidence
other than strict conservation of residues in a multiple
sequence alignment. Our goal was to use MUSE to
identify key amino acids in I-BmoI for proof-of-principle
experiments, highlighting the utility of the MUSE frame-
work. We anticipate that our data will form a platform on
which to pursue future structure and function studies of
GIY-YIG homing endonucleases and other proteins con-
taining the GIY-YIG domain, and that the MUSE
approach will be generally applicable to a broad range
of proteins.
Application of MUSE to GIY-YIG homing endonucleases
Past studies on GIY-YIG enzymes have utilized align-
ments and structural data to identify a set of absolutely
conserved residues, subsequent mutation of which abol-
ished cleavage activity. The residues were chosen for
mutational analyses on the assumption that conserved
residues are important for function, and likely are compo-
nents of the enzyme’s active site. Such approaches,
however, provided limited mechanistic insight and would
miss residues that are not universally conserved amongst
GIY-YIG enzymes, but nonetheless may be functionally
critical. Furthermore, alignments of GIY-YIG containing
proteins are dominated by the nucleotide excision repair
protein, UvrC, which has a diﬀerent set of functional con-
straints than GIY-YIG homing endonucleases. Thus, one
aspect of the MUSE approach was to assemble an align-
ment of GIY-YIG proteins that closely resembled known
homing endonucleases, with the goal of enhancing the
information speciﬁc to GIY-YIG homing endonucleases.
For instance, it is known that  140 well-aligned sequences
will provide suﬃcient information for covariation analyses
to detect co-evolving residues (4). As discussed below,
the strongest co-evolving amino-acid pair detected by
covariation analyses was S20-I71. One of these residues,
I71, has not previously been identiﬁed for mutational
analyses because this position is highly variable in
multiple sequence alignments, yet our data indicate that
I71 is a functionally signiﬁcant residue.
That I-BmoI is a site-speciﬁc endonuclease was another
critical factor in this study, facilitating the use of a genetic
selection where survival in the assay was dependent on
endonuclease function. Survival could also be inﬂuenced
by the solubility or stability of I-BmoI variants. We found,
however, that very low levels of I-BmoI expression were
required for survival in the selection, suggesting that sol-
ubility was not likely a factor. Furthermore, use of a func-
tional genetic selection allowed us to screen through a
large population of I-BmoI variants mutagenized over
the entire coding region, thus avoiding biases introduced
by localized mutagenesis of speciﬁc residues or regions of
the protein. Using the EoS method for analysis of unigenic
evolution data, we obtained suﬃcient power to identify
residues of potential functional signiﬁcance for a protein
the length of I-BmoI (266 residues) by sequencing a rela-
tively small number of selected (87) and unselected (62)
clones. In addition to identifying residues of potential
importance, MUSE is also expected to identify positions
that are tolerant to mutation (hypermutable). For
instance, N12 was mutated 10 times in the selected
clones as opposed to 7 times in the unselected clones,
Table 3. DNA cleavage by WT I-BmoI and variants identiﬁed
by MUSE
protein k1 (s
 1)
a k2 (s
 1)
b
WT 0.080±0.0033 0.034±0.00069
N12D 0.073±0.0045 0.024±0.00081
I71N 0.045±0.0028 0.015±0.00051
S20Q 0.012±0.003 N.D.
I67N 0.036±0.0005 N.D.
ak1 is the rate constant for the ﬁrst nicking step that generates nicked
intermediate from circular substrate. For S20Q and I67N, k1 is valid
only at the initial time point (Supplementary Figure S4).
bk2 is the rate constant for the second nicking step that generates a
linear product.
N.D., not determined.
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expected to drastically aﬀect I-BmoI function. Indeed,
our in vitro analyses of the N12D mutant (the most
common mutation at that position) indicate essentially
WT levels of activity, validating that the MUSE frame-
work has the power to distinguish between residues in
I-BmoI the catalytic domain that are functionally impor-
tant and those that are not.
Residues within the GIY-YIG domain of I-BmoI that are
important for function
The proposed catalytic mechanism for the GIY-YIG
domain is based on the predicted function of a set of
conserved residues (Y17, R27, E74 N87), each with
distinct roles (21,25). Y17 is thought to act as a general
base to activate a nucleophilic water; R27 may stabilize
the 50 phosphate of the cleavage intermediate, or contact
substrate; E74 coordinates a divalent metal ion that likely
functions as the Lewis acid; and N87 is thought mainly to
have a structural role in maintaining the active site archi-
tecture. Mutation of any of these residues to alanine
abolishes cleavage activity, an uninformative phenotype
as limited mechanistic insight is gained from catalytically
inactive mutants. Hence, many unanswered questions
remain regarding the catalytic mechanism of the
GIY-YIG domain. For instance, the path of substrate
DNA has only been inferred from the position of the
conserved residues in the catalytic domain. In this
regard, it is worth noting that an I-BmoI R27A mutant
displayed a loss of hypersensitivity in footprinting exper-
iments compared to WT protein (27), suggesting that the
R27A mutant possesses a DNA contact defect that would
not be expected if R27 functioned as a catalytic residue.
Thus, additional types of evidence other than structural
data are needed to deﬁnitively assign functional roles to
the presumed set of catalytic residues. Moreover, the sig-
niﬁcance of residues that lie very close to the proposed
active site of I-TevI and UvrC are unknown, and have
largely been ignored because they are not conserved in
multiple sequence alignments. In the following sections,
we discuss the potential structural and functional signiﬁ-
cance of residues identiﬁed by MUSE for which subse-
quent mutagenesis revealed eﬀects on I-BmoI cleavage
activity.
S20 and I71
The S20-I71 pair was chosen for further study because this
pair was the highest scoring set of co-evolving residues
(Table 1 and Supplementary Table S4). In the GIY-YIG
domain alignment, S20 and I71 are both poorly conserved
positions (but are conserved between I-BmoI and I-TevI),
and are most commonly varied to glutamine and
asparagine residues, respectively. In the I-BmoI
homology model and the I-TevI structure, the residues
are located in the proposed catalytic surface (Figure 9).
In the I-TevI structure, S20 lies within hydrogen-bonding
distance of the metal-coordinating residue E75, and could
potentially position E75 or stabilize the interaction of E75
with divalent metal ion. Intriguingly, I71 can be structur-
ally aligned with L116 of the His-Cys box homing
endonuclease I-PpoI, where the residue is inserted into
the minor groove of its homing site substrate (42,43).
Further evidence for signiﬁcant roles of S20 and I71
stemmed from the unigenic evolution data, as S20 pos-
sessed an EoS score of 3.25 and I71 possessed a score of
6.37. Neither position was mutated in the selected clones,
whereas both positions were mutated in the unselected
clones (Supplementary Table S3). We made S20A and
S20Q mutations and found that the S20A mutant did
not survive the genetic selection, whereas S20Q had a
survival ratio of 0.063. Cleavage assays with S20Q
revealed that at high protein concentrations the enzyme
retained  30% activity of WT protein, and a similar
reduction in cleavage activity was observed when the
equivalent residue in UvrC (K32) was mutated (21).
Both I71 mutants (I71A and I71N) survived the genetic
selection, but with reduced ratios relative to WT I-BmoI.
We puriﬁed the I71N mutant for further analysis, and
found that it had slightly reduced activity relative to WT
protein. Importantly, time-course cleavage assays revealed
Figure 9. Summary of functionally relevant residues identiﬁed by MUSE. Shown are ribbon (left) and surface (right) representations of the I-BmoI
catalytic domain with the residues identiﬁed by MUSE (S20, H31, N42, I67 and I71) highlighted in green, and previously identiﬁed functionally
critical residues (Y17, R27, E74 and N87) shown in black. The catalytic cleft is highlighted as in Figure 1C.
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for WT protein (Figure 8). Because I-BmoI generates a
DSB by two independent and sequential nicking reactions
(27), the phenotype of the I71N mutant implies a defect in
the second nicking reaction. While the mechanistic basis
of this defect will require future study, it is possible that
I71 functions in substrate recognition, and that the I71N
mutation greatly reduces substrate interactions that eﬀect
the second nicking reaction.
One intriguing question regarding the S20 and I71
residues is why do they co-evolve? It is worth noting
that the predicted distance separating the residues
( 6A ˚ ) could reﬂect a limitation of the homology model
of the I-BmoI catalytic domain, as these residues are
 3.5A ˚ apart in the I-TevI structure. In the 146 sequences
used for mutual information analyses, position 20 is most
commonly a serine, and position 71 is most commonly an
isoleucine. However, there are almost equal occurrences of
Q20-N71, Q20-D71 and S20-L71 pairs among the
sequences. We attempted to rescue the S20Q mutant by
making a second site mutation in position I71, generating
a S20Q/I71N double mutant, reasoning that this double
mutant represented a tolerated amino-acid pairing at posi-
tions 20 and 71. However, the S20Q/I71N double mutant
did not survive the genetic selection, suggesting that this
combination of residues is not tolerated in the I-BmoI
background, and that changes at other positions would
be required to restore activity. Both S20 and I71 are in
close proximity to the proposed metal-binding residue,
E74 (E75 in I-TevI), implying that certain combinations
of residues may be favoured for correct positioning of the
metal-binding residue within the active site (Figure 9).
H31
H31 was chosen for further analysis due to its high infor-
mation content in the alignment, the observation that this
position has a relatively high EoS score of 3.52, and a lack
of mutations in the selected clones (but multiple mutations
were present in the unselected clones; Supplementary
Table S3). H31 is well conserved amongst GIY-YIG
endonucleases, but is replaced by a tyrosine in the equiv-
alent position in UvrC (Y43). In the homology model and
I-TevI structure (Figure 9), H31 packs against the side
chain of R27 and is within hydrogen bonding distance
of both H40 and Y6, but no potential functional
role was assigned to H31 based on the I-TevI structure.
In the UvrC structure, Y43 was proposed to act as a
general base to deprotonate a nucleophilic water
molecule (21). To test the importance of H31 in I-BmoI,
we made three mutations, H31A, H31F and H31Y, rea-
soning that the H31F would be structurally similar but
chemically inert, while H31Y might retain limited
function. Intriguingly, the H31F and H31Y mutants did
not survive the genetic selection, while the H31A mutation
had a very low survival ratio (Table 2). Unfortunately,
the H31Y mutant proved to be insoluble and could not
be studied in vitro, whereas no cleavage activity could be
detected in vitro with the H31A mutant using
plasmid-based cleavage assays. The H31A mutant may
retain an extremely low level of activity that is diﬃcult
to detect using non-radioactive substrates, but that may
be suﬃcient to permit very a low level of survival in the
genetic selection. These data provide the ﬁrst evidence that
H31 may play an important role in the active site of
I-BmoI and other GIY-YIG endonucleases, either func-
tioning as a base, by stabilizing the active site architecture
by forming a hydrogen bond network with Y6 and H40,
or by contacting substrate.
N42
N42 was chosen for mutational studies because it pos-
sessed a high EoS score of 6.49 (Figure 5 and
Supplementary Table S4). In the GIY-YIG domain align-
ment, position 42 has little information content, although
there is a tendency for this position to be a polar residue.
N42 is located in a loop connecting a-helix1 and a-helix2,
and is orientated so that the side chain points towards the
predicted active site surface (Figure 9). Interestingly, the
amino group of N42 is within hydrogen bonding distance
of the hydroxyl group of the functionally critical Y17. We
made two mutations that would disrupt this interaction,
N42A and N42D, and found that both mutants did not
survive the genetic selection, and that the N42D mutant
displayed no cleavage activity in vitro. N42 may be critical
because it functions to correctly position Y17 within the
active site of the enzyme.
I67
Like I71, I67 is not conserved amongst GIY-YIG
endonucleases, with this position displaying no informa-
tion content (Figure 2, Supplementary Table S4). In the
homology model of the I-BmoI catalytic domain, I67 is
positioned in a loop connecting a-helix 3 and b-sheet 3,
with its side chain pointed towards the active site surface
(Figure 9). Mutation to asparagine reduced in vitro
cleavage activity to approximately half that of WT
I-BmoI, with defects in both the ﬁrst and second nicking
reactions (Figure 8). We envision that I67 may be involved
in substrate interactions, similar to a role for I71.
Residues outside of the catalytic domain predicted to be
critical for function
GIY-YIG homing endonucleases are modular proteins,
with the N- and C-terminal domains connected by a
ﬂexible linker. Past studies on the I-TevI linker have
revealed that the linker is required to correctly position
the N-terminal GIY-YIG domain on substrate for eﬃcient
cleavage (17,18,44). Remarkably, the linker can extend or
retract to correctly position the catalytic domain on
substrates that contain insertions or deletions that move
the preferred cleavage sites from their WT position. This
property of the linker has led to the proposal that I-TevI,
and perhaps other GIY-YIG endonucleases, generates a
DSB by a conformational change mechanism, whereby the
linker is a critical component in repositioning the catalytic
domain between the bottom- and top-strand nicking reac-
tions. Interestingly, I-BmoI can also reposition the
catalytic domain to cleave substrates with +5 and +10
insertions (18), suggesting that the I-BmoI linker functions
analogously to the I-TevI linker in spite of limited
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linker region. Intriguingly, our unigenic evolution data
revealed that many residues within the I-BmoI linker
region are predicted to be functionally signiﬁcant.
Notably, K105 and K111, conserved between I-TevI and
I-BmoI, have EoS scores greater than 8. These residues
correspond to the deletion intolerant region of the
I-TevI linker, where 2- or 3-amino-acid deletions abolish
cleavage activity, although the functional basis for this
phenotype is unknown (17,19). Furthermore, two addi-
tional sets of residues in the I-BmoI linker, centered on
Y120 and K130, also have high EoS scores. Our data
clearly implicate the I-BmoI linker as important for
function, and identify a set of residues for future
mutagenesis and functional studies.
Apart from a repeated nuclease-associated modular
DNA-binding domain motif (NUMOD3) (45), I-BmoI
shares little amino-acid similarity with I-TevI in the
C-terminal DNA-binding domain, even though the
enzymes are isoschizomers and bind the same stretch of
thymidylate synthase sequence in Bacillus mojavensis and
phage T4, respectively (32). The NUMOD3 motif corre-
sponds structurally to a minor-groove binding a-helix that
was ﬁrst identiﬁed in the co-crystal of the I-TevI
DNA-binding domain with its homing site substrate
(46), and later in the structure of an unrelated HNH
endonuclease, I-HmuI (47). In the I-TevI structure, the
a-helix is positioned along the minor groove of its DNA
substrate, and only one residue in the a-helix (S191) makes
a single hydrogen bond contact to the phosphate
backbone. Immediately preceding the a-helix, however,
is H182 that makes two base-speciﬁc hydrogen bonds.
Based on sequence predictions, I-BmoI possesses three
NUMOD3 motifs, with H147, H175 and H202 corre-
sponding to the critical H182 of I-TevI. The EoS scores
for the three histidine residues in I-BmoI are extremely
low (Figure 5), and each position had multiple substitu-
tions in the selected clones (Supplementary Table S3), sug-
gesting that these residues perform diﬀerent functions
than the equivalent H182 of I-TevI. Similarly, residues
that comprise the predicted I-BmoI helix-turn-helix
(HTH) motif at the C-terminal end of the DNA-binding
all have low EoS scores (Figure 5). In I-TevI, the analo-
gous HTH motif makes extensive hydrophobic contacts
with thymine residues in the substrate, providing
speciﬁcity to the I-TevI substrate interaction. The toler-
ance of the I-BmoI HTH to mutation implies that it may
function diﬀerently than the analogous HTH motif of
I-TevI, and a detailed study of the sequence requirements
for DNA binding by both HTH motifs would provide an
intriguing comparative study.
CONCLUSION
Using a uniﬁed experimental approach that synthesizes
three distinct types of data, we have identiﬁed previously
unknown functionally relevant residues in the GIY-YIG
homing endonuclease I-BmoI. Our results will form a
platform for future studies of I-BmoI and other
GIY-YIG-domain containing proteins because residues
identiﬁed by MUSE, when mutated, generate distinct
phenotypes that will provide mechanistic insight. Many
of the positions identiﬁed by MUSE are non-conserved,
and have escaped detection by traditional analyses such as
strict conservation in multiple sequence alignments, pro-
viding a cautionary tale against using only a single meth-
odology for structure and function studies. We anticipate
that the MUSE framework will be generally applicable to
a wide range of protein families, requiring  140
well-aligned paralogous sequences, an enzymatic activity
that forms the basis for a genetic selection and, although
not essential, a structural model on which to interpret the
MUSE data. For instance, the MUSE framework can
be applied to any homing endonuclease or DNA
endonuclease without diﬃculty, and would greatly aid in
the re-design of endonucleases against novel target
sequences. Unigenic evolution screens have been applied
to eukaryotic proteins, including human Pin1 (a prolyl
isomerase) and yeast TFIIB (48,49), and each of these
proteins could be also analysed within the MUSE
framework.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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